Bipolar Disorder Patients Respond to Ketamine, Esketamine Treatment
December 3, 2024 · Posted in B - Clinically Important for Future Consideration, Current Treatments, Potential Treatments · Comment
(Reposted from the Yale School of Medicine blog)
A small sample of patients with bipolar disorder displayed noteworthy improvement in their depressive symptoms after being treated with the rapid-acting antidepressant intravenous ketamine and the nasal spray esketamine, according to a new Yale led-study.
The study, published October 2 in the Journal of Clinical Psychiatry, also found that patients were not at higher risk of suffering a manic episode during the acute phase of treatment.
